Skip to content
IP Osgoode
  • ABOUT
  • OUR TEAM
    • DIRECTOR
    • MEMBERS
    • ADVISORY BOARD
    • SPONSORS
  • IPILOGUE
    • BLOG
    • IPILOGUE EDITORS
    • GOWLING WLG PRIZE
    • IPIGRAM ARCHIVE
  • INNOVATION CLINIC
    • ABOUT
    • BECOME A CLIENT
    • CLINIC FELLOWS
    • FAQS
  • IP INTENSIVE
    • ABOUT
    • PLACEMENTS
  • RESEARCH
    • IP LAW & POLICY
    • INNOVATION
    • LAW REFORM
  • EVENTS
    • PAST EVENTS
  • OTHER ACTIVITIES
    • IP WRITING CHALLENGE
    Home
    >
    IP
    >
    Patents
    >
    Pharmaceutical Drugs

    Category: Pharmaceutical Drugs

    July 12, 2018in Innovation, IP, Patents, Pharmaceutical Drugs0by Editor
    187

    Innovating with Yesterday’s Inventions: Repurposing Drugs for New Indications

    Pharmaceutical research and development (R&D) has skyrocketed in recent years and is projected to reach even greater levels in the future. The total R&D spending has increased by 33 billion…

    Read more
    August 16, 2017in Access to Medicines, Blogs, Commercialization, Development, Innovation, Patentability, Patents, Pharmaceutical Drugs, Uncategorized0by Editor
    299

    Broken Promises: Utility Standards and Patent Applications in Canada

    The last day of June 2017 saw the Supreme Court of Canada (SCC) quash the controversial Promise Doctrine. The issue at hand in AstraZeneca Canada Inc v Apotex Inc was…

    Read more
    January 11, 2017in Access to Medicines, Commercialization, Design, Development, IP, Patentability, Patents, Pharmaceutical Drugs, Uncategorized0by Editor
    265

    What Makes It My Molecule: A Look at Professor Ronald Pearlman’s Genome Editing Work

    This past November, Professor Ronald E. Pearlman from York University’s Department of Biology gave a talk [1] at Osgoode Hall Law School to discuss the potential of the innovative CRISPR…

    Read more
    December 6, 2016in Blogs, IP Intensive, Patents, Pharmaceutical Drugs, Regulatory Policy0by Editor
    131

    Bringing Biologics in from the Cold: Does Canada’s IP Regime Need a Booster?

    As ratification stutters for the Comprehensive Economic and Trade Agreement (CETA), the much-maligned free-trade deal between Canada and the European Union, debate continues as to whether the Canadian intellectual property…

    Read more
    March 7, 2016in Canada, Innovation, Patents, Pharmaceutical Drugs, Uncategorized0by Editor
    102

    Pharmaceuticals Main Attraction in TPP IP Chapter

    Patent law can be a polarizing topic, but it is especially so during international trade negotiations. Perhaps this is because the principles of patent law create fundamental conflicts between those…

    Read more
    December 18, 2015in Blogs, Canada, IP, IP Intensive, Patentability, Patents, Pharmaceutical Drugs1by Editor
    140

    The Not-So-Obvious Aspects of an Obviousness-Type Double Patenting Analysis

    The granting of a patent has often been described as a bargain [1] between the government and the patentee. In exchange for the exclusive right [2] to make, construct, use…

    Read more

    Posts navigation

    1 2 … 17
    Search
      Categories
      IP Osgoode
      © Osgoode Hall Law School, York University
      • Privacy & Legal
      Osgoode Hall Law School, York University
      Ignat Kaneff Building
      4700 Keele Street
      Toronto, Ontario  M3J 1P3
      Canada

      T:416.736.5030   F:416.736.5736